• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC UNIVERSA FIRM URETERAL STENT SET; FAD STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC UNIVERSA FIRM URETERAL STENT SET; FAD STENT, URETERAL Back to Search Results
Model Number G23399
Medical Device Problem Codes Calcified (1077); Material Separation (1562)
Health Effect - Clinical Code Device Embedded In Tissue or Plaque (3165)
Date of Event 03/07/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Concomitant products: ptfe 0.038 guidewire, soflex 6fr catheter, flexor access sheath 9.5fr.(b)(6).This report includes information known at this time.A follow up report will be submitted should additional relevant information become available.
 
Event or Problem Description
It was initially reported on 12apr2019, the customer has recently noticed severe encrustations occurring on the ufh stents and removal issues.They had not retained any devices for investigation.Customer was asked to please retain stents for analysis if issue occurs.Additional information was provided on 19apr2019.The coating of the device was activated with saline, although it is unknown how long it was activated.The device was accessed through the ureteric orifice.The patient has been diagnosed as being a stone former, having the pre-existing condition of renal calculi.The device was removed, then replaced with difficulty.There are no photos, images, or videos available, nor pathology reports.It is unknown if any intervention, additional procedures, and/or medications have been administered.New information was received on 29apr2019: on (b)(6) 2019, performed planned procedure and the universa firm ureteral stent was inserted.On (b)(6) 2019, patient returned for planned procedure and it was noted that the stent was encrusted.Tried to remove it, but was only able to remove the bottom end.Nephrostomy tube was required and inserted on (b)(6) 2019.Based on the information received on 29apr2019, this occurrence has been determined to be a reportable event.In response to the request for addition information with regards to storage of the devices, the following information was provided on 03may2019.They are kept in the boxes until required in a drawer cupboard.The boxes are upright.When they are getting ready to use them they are transferred into plastic trays, the box was removed from some and they were laid flat.The trays were not over stocked and the stents which were out of the box were stacked 3-5 units high.
 
Additional Manufacturer Narrative
Investigation ¿ evaluation : a visual inspection of the returned device was conducted.A document based investigation was also performed including a review of complaint history, device history record, the instructions for use(ifu), manufacturing instructions, specifications, and quality control data.The complainant returned one universa firm stent for investigation.Complaint lot number was confirmed.Visual examination confirmed two segments of a 5fr universa stent were received in used condition.Distal segment measures 7.5cm from the coil with a straight cut severed edge.Medium to light calcification starts at the tip of the coil ending at the severed point.Proximal coil segment measures 9.2 cm from the coil with an angle cut at the severed edge.Heavy calcification noted on the outside of the coil with calcification visible inside the tubing at the severed point.Total length of the returned pieces measures 16.7 cm.Point of separation on each segment is noted to not have mating fractures.This indicates part of the stent body was not returned.A document based investigation evaluation was conducted.There is no indication that manufacturing or quality controls contributed to this incident.A review of the device history record found no non-conformances related to the reported failure mode.A review of complaint history revealed no additional complaints associated with the complaint device lot.Because there are no related non-conformances, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, it was concluded that there is no evidence that nonconforming product exists in house or in field.A review of sales was carried out to identify customers who purchased both the ufh/ush and usi/ufi stent lines which are products the originating customer had switched between.During the time period 01jan2018-04jun2019, 19 customers purchased both product lines (10+ units of both lines) and only the customer who reported this complaint has identified a difference in encrustation rates.Instruction for use (ifu) cook conducted a review of the ifu for this product.The following cautions relevant to this complaint are supplied with this device: "the universa® firm stents must not remain indwelling more than twelve (12) months.The universa® soft stents must not remain indwelling more than six (6) months.If the patient¿s status permits, the stent may be replaced with a new stent." "these stents are not intended as permanent indwelling devices." "tether should be removed if stent is to remain indwelling longer than 14 days." "do not force components during removal or replacement.Carefully remove the components if any resistance is encountered." "individual variations of interaction between stents and the urinary system are unpredictable." "periodic evaluation via cystoscopic, radiographic, or ultrasonic means is suggested.The stent must be replaced if encrustation hampers drainage." based on the information provided, inspection of returned product and the results of the investigation, the cause of the complaint is attributed to a known inherent risk of the device.The device is supplied with instructions for use which includes cautions which refer to monitoring for stent encrustation and that individual variations of interaction between stents and the urinary system are unpredictable.The fact that stents are in the urinary tract already predisposes the device to urine¿s elements.Ureteral stent encrustation is a known inherent risk of the device.Per the quality engineering risk assessment, no further action is warranted.Cook medical has notified the appropriate personnel and will continue to monitor this device via the complaints database for similar complaints.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
There is no new patient or event information to report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNIVERSA FIRM URETERAL STENT SET
Common Device Name
FAD STENT, URETERAL
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key8609343
Report Number1820334-2019-01046
Device Sequence Number16667148
Product Code FAD
UDI-Device Identifier10827002233994
UDI-Public(01)10827002233994(17)211011(10)NS9229333
Combination Product (Y/N)N
Initial Reporter CountryGB
PMA/510(K) Number
K961446
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 08/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/11/2021
Device Model NumberG23399
Device Catalogue NumberUFH-528-RT1
Device Lot NumberNS9229333
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/26/2019
Initial Date Received by Manufacturer 04/12/2019
Supplement Date Received by Manufacturer07/29/2019
Initial Report FDA Received Date05/14/2019
Supplement Report FDA Received Date08/20/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age50 YR
Patient Weight85
-
-